[1] Van Der Meersch H,De Bacquer D,Vandecasteele S J,et al. Hemodialysis catheter design and catheter performance:a randomized controlled trial[J]. Am J Kidney Dis,2014,64(6):902-908. [2] Schwab S J,Beathard G.The hemodialysis catheter conundrum:hate living with them,but can't live without them[J]. Kidney Int,1999,56(1):1-17. [3] Malinoski D,Ewing T,Patel M S,et al.Risk factors for venous thromboembolism in critically ill trauma patients who cannot receive chemical prophylaxis[J]. Injury,2013,44(1):80-85. [4] Leung A,Heal C,Perera M,et al.A systematic review of patient-related risk factors for catheter-related thrombosis[J]. J Thromb Thrombolysis,2015,40(3):363-373. [5] Karaaslan H,Peyronnet P,Benevent D,et al.Risk of heparin lock-related bleeding when using indwelling venous catheter in haemodialysis[J]. Nephrol Dial Transplant, 2001,16(10):2072-2074. [6] Hilleman DE,Dunlay RW,Packard K A.Reteplase for dysfunctional hemodialysis catheter clearance[J]. Pharmacotherapy, 2003,23(2):137-141. [7] Thomson PC,Morris ST,Mactier RA.The effect of heparinized catheter lock solutions on systemic anticoagulation in hemodialysis patients[J]. Clin Nephrol,2011,75(3):212-217. [8] Holley JL,Bailey S.Catheter lock heparin concentration:effects on tissue plasminogen activator use in tunneled cuffed catheters[J]. Hemodial Int,2007,11(1):96-98. [9] Ivan D M,Smith T,Allon M.Does the heparin lock concentration affect hemodialysis catheter patency?[J]. Clin J Am Soc Nephrol,2010,5(8):1458-1462. [10] Bouvet M,Gamagami RA,Gilpin EA,et al.Factors influencing survival after resection for periampullary neoplasms[J]. Am J Surg, 2000,180(1):13-17. [11] Palomo I,Pereira J,Alarcón M,et al.Prevalence of heparin-induced antibodies in patients with chronic renal failure undergoing hemodialysis[J]. J Clin Lab Anal,2005,19(5):189-195. [12] Macrae J M,Dojcinovic I,Djurdjev O,et al.Citrate 4% versus heparin and the reduction of thrombosis study (CHARTS)[J]. Clin J Am Soc Nephrol,2008,3(2):369-374. [13] Grudzinski L,Quinan P,Kwok S,et al.Sodium citrate 4% locking solution for central venous Dialysis catheters——an effective,more cost-efficient alternative to heparin[J]. Nephrol Dial Transplant,2007,22(2):471-476. [14] Ortel TL.Acquired thrombotic risk factors in the critical care setting[J]. Crit Care Med,2010,38(2 Suppl):S43-S50. [15] Pepper RJ,Gale DP,Wajed J,et al.Inadvertent postdialysis anticoagulation due to heparin line locks[J]. Hemodial Int,2007,11(4):430-434. [16] Polaschegg HD,Shah C.Overspill of catheter locking solution:safety and efficacy aspects[J]. ASAIO J,2003,49(6):713-715. [17] Ashman N.Efficacy of sodium citrate antimicrobial locks for reducing rates of catheter-related bacteremia[J]. Am J Kidney Dis,2009,54(6):1185;author reply 1185-1185;author reply 1186. [18] Oliver MJ,Callery SM,Thorpe KE,et al.Risk of bacteremia from temporary hemodialysis catheters by site of insertion and duration of use:a prospective study[J]. Kidney Int,2000,58(6):2543-2545. |